News

Get started, the platform opens in 2 weeks!

Efficiently identify and meet up with up to 30 potential partners over the 2 Days event!

From large biotech and pharma companies to innovative start-ups, investors, TTOs, and academia,

follow the next steps to put all the chances on your side:

STEP 1 :

Create your personal and company profile as well as your licensing opportunities in order for the other participants to find you. More your profile will be completed, more you will have meetings requests and acceptation to your requests.

STEP 2 :

Your profile is now completed, in 2 weeks you could search for companies, participants or licensing opportunities and send meetings requests.

STEP 3 :

Accept or decline requests from others. Your meetings schedule will be based on the meetings you’ve accepted & your accepted resquests.

 

You’re not yet registered for BioFIT? Hurry up, register now!

Are you a Technology Transfer professional attending BioFIT? Then come and join us and learn more about Capacity building technology transfer

 

This round table discussion will tackle issues like:

• How to approach Capacity Building technology transfer?
• Is there a “one size fits all” solution?
• Is The Best Practise transferable to every TTO in every country and applicable in each (regional) situation?

 

ASTP-Proton invites you to this interactive session to share your expertise and explore the possibilities to come to a better common understanding of CBTT.

This topic will be adressed by 3 high-league speakers from ASTP-Proton :

• Christian Stein, CEO of Ascenion and President of ASTP-Proton
• Jon Wulff Petersen, consultant of ASTP for the ProgressTT projec and member of the board of ASTP as vice president for program
• Erik Vane, General Manager of ASTP-Proton

We are already looking forward to attending this promising session !

Discover the full speaker list here, and the conference program here

Want to speak at BioFIT? Contact us!

Your project is related to :

• immunology
• oncology
• immuno-oncology
• cardiometabolic diseases
• infectiology & vaccines
• devices & imaging

 

 

Don’t wait anymore, apply for the Posters & Presenting technologies session, which includes:

• your poster displayed during Day 1 & 2 of BioFIT
• the possibility to be selected by our jury to give an oral presentation during Day 1 or Day 2 of BioFIT.

 

The best way to promote your project!

Deadline to send us the application documents filled & signed : OCTOBER 23rd.

Contact us for more information

Download the application documents.

Plenary session speaker Marisol Quintero shared inspiring thoughts on her professional career and on Academia/industry relationships.

CEO of BiOncoTech Therapeutics, Marisol Quintero runs a biopharmaceutical company based in Spain, and dedicated to the research and development of new treatments in the field of oncology.

 

1. You are CEO of Bioncotech Therapeutics, a biopharmaceutical company dedicated to the development of new oncologic treatments. You have an interesting professional career, going from research to technology transfer and then industry, what led you through this path?

I didn’t plan my career in advance, when I was doing my PhD I was dedicated to that task, however once I finished I realized I wanted to “practice” science from a translational point of view. Technology Transfer represents the interphase between academia and industry, and although not everyone that goes into TT will end up in industry, I would say most of them will have the right skills to work in certain industry positions.

2.      Based on this particular background, how do you think academia/industry dialogue can be improved in order to foster innovation in life sciences?

I think both ends benefit from sharing a common language, and that is why having professionals that understand academia and industry priorities is important. Professionalization of Tech Transfer positions in academia really helps. Now that I have seen the whole picture I also understand the constraints that some academic centres have I will say we need to make sure industry professionals come up with original ideas on how to establish fruitful collaborations.

3.      How do you see the Life Sciences sector in 10 years ? Which evolutions do you think will take place? What do you wish to see happen?

We are seeing more collaborations between industry and academia, and new models are now being tested. I don’t think there is a model that works best, it probably depends on the circumstances. I think science coming from academia will drive innovation in the life science industry and we will see big achievements in the med-tech discipline. Companies able to identify innovative projects and capable of managing their translation into new products or services will be more successful. I would like to see that academia is a stake holder of the innovation path and as such takes more risks and gets more rewards.

4.     Who/what inspires you?

I was very lucky to have a great scientist as a mentor. Salvador Moncada has a clear idea on how to translate science into business and was able to inspire me to do what I do now. My motivation has always been the same, to be very close from science and connect it to those able to put into practice.

5.     What would be your advice to young entrepreneurs in the Life Sciences industry?

Keep trying! Most of the projects that start-ups develop will probably not succeed, however that is not a bad thing, is how it works. I would advice them to dedicate some time to learn about management and finance, and to take advantage from academic collaborations.

6.   At BioFIT you are one of the Plenary Session’s panelists debating on “Who drives innovation in Life Sciences : academia or industry?”. Why do you think  BioFIT participants should attend this session?

It will be a great opportunity to understand how industry and academia would like to work together.

7.      What are, in your opinion, the 3 words that describe BioFIT ?

“Where innovation meets”

Want to know more on BioFIT 2015 conference program ? Check the full agenda!

Interested in speaking in BioFIT 2015 ? Contact us!

The very exciting session “How to partner more efficiently with charities, patient groups and foundations” got its last panelist confirmed this week!

Scheduled at 9 am to kick-off day second, this session will discuss the pros and cons of partnerships with charities, patient groups, and foundations. Our panelists will discuss the successful models they had the opportunity to take part in, create, or manage, and their aftermaths.

Furthermore, we will go deeper by addressing the downsides of these partnerships: it is not always easy to attract the charities and foundations to invest in start-ups or research projects. Though charities and foundations have been increasingly supporting start-up companies, early-stage projects and project development leading start-ups, it is complicated for them to spot the right project, to find the right innovation and target the molecules that have potential,  how can TTOs and research institutes improve the dialog to set up more efficient collaborations?

Moderated by Thomas Dentzer, General manager of Luxembourg BioHealth Cluster, this session will feature panelists profiles as varied as they are completing each other :

–        Robin Rasor, CEO of the TTO spin-off, University of Michigan, USA

–        Olivier Arnaud, Director Research Europe, JDRF, France

–        Sohini Chowdhury, VP Research Partnerships, the Michael J Fox Foundation, USA

–        Jerôme Van Biervliet, Senior Development Manager, VIB, Belgium

 

We are already looking forward to listening to these heavy league speakers !

Discover the full speaker list here, and the conference program here

Want to speak at BioFIT? Contact us!

 

Pharmaceutical Tech the Global Leader in B2B services supports BioFIT!

 

In the realm of Pharmacy, where innovation is rapid :

Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space

&

BioFIT is the perfect place to find the perfect match

 

Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers.

Pharmaceutical-Tech.com covers in-depth trends that shape industry dynamics and metamorphose global economics.

With services like search engine optimization, global magazine, social media marketing, product video showcase, e-mail marketing, e-newsletter sponsorship, banner advertising, event marketing and micro-website within our platform, www.pharmaceutical-tech.com has created a recognition that spans over a global audience, thereby revolutionizing how businesses transact.

Steering Committee member and panelist Cécile Théard-Jallu,  partner at de Gaulle Fleurance et Associés, France, shared a few words on the importance of using the law as a tool to develop your projects :

The law as a crucial tool within the innovation framework, is a topic mentionned in some of BioFIT 2015 sessions.

 

First, the subject is thoroughly developed in the session “Shaping the future of Open-Innovation :  does the IP legal framework need remodeling ?” addressed by 4 high-level experts :

–        Moderator : Timo Minssen, Associate Professor, University of Copenhagen, DK

–        Philippe Borne, Regional Representative Strasbourg, INPI Alsace, FR

–        Gauthier Obrecht, Patents Biotech Manager, Boerhinger Ingelheim, DE

–        Sumitra Rajagopala, CEO of BioAstra Technologies, CA

 

Moreover, on December 2nd in the session “How to implement and perform scientific and technological Due Diligence?” scheduled at 2pm, alongside Diane Seimetz, Co-founder, BioPharma excellence, DE, Carl Jessop, Due Diligence Director, Astrazeneca, UK,  David Malek, VP Business Development, Biolinerx, Israel and Martin Cadman, Director Scientific Licensing, GlaxoSmithKline, Cécile Théard-Jallu will share her expertise on the topic from a legal point of view.

 

So, is the law a tool or a constraint ? Come share your opinion at Biofit2015!

 

Discover the full speaker list here, and the conference program here

Want to speak at BioFIT? Contact us!

From small to big organizations, as our confirmed exhibitors,

find the perfect exhibition package to highlight your visibility during BioFIT 2015!

 

Besides highlighting your visibility, the exhibition has many other advantages :

• Improving your company’s image, prestige and credibility,
• Getting identified as a key innovative actor in Life Sciences,
• Reassert your corporate focus on innovations
• Speeding up your business strategy,
• Getting additionnal networking opportunities.

Check the exhibition packages.

You want to discover who you will meet in the exhibition area?

Check the full exhibitors’ list.

You have a technology to promote?

BioFIT and the SATT network (the association of the French TTOs), jointed their initiatives to launch the Technomarket & Presenting Technologies session during BioFIT 2015.

The presenting technologies aims at matching the needs of academia, TTO and academia spin-off seeking alliances and business development opportunities on innovative projects.

 

If your innovative product, technology, knowhow or research result is related to :

• devices / imaging
• cardio metabolic diseases
• immunology / oncology
• infectious diseases / vaccines

apply for the Technomarket & Presenting Technologies sessions and have the chance to present it during BioFIT !

For more information, contact us!